Palatin Technologies (PTN) Competitors $0.09 -0.08 (-44.65%) As of 05/7/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock PTN vs. CYCN, ORGS, BMRA, ACXP, CELZ, PHIO, SNSE, NEUP, BCLI, and ADXNShould you be buying Palatin Technologies stock or one of its competitors? The main competitors of Palatin Technologies include Cyclerion Therapeutics (CYCN), Orgenesis (ORGS), Biomerica (BMRA), Acurx Pharmaceuticals (ACXP), Creative Medical Technology (CELZ), Phio Pharmaceuticals (PHIO), Sensei Biotherapeutics (SNSE), Neuphoria Therapeutics Inc. - Common Stock (NEUP), Brainstorm Cell Therapeutics (BCLI), and Addex Therapeutics (ADXN). These companies are all part of the "pharmaceutical products" industry. Palatin Technologies vs. Cyclerion Therapeutics Orgenesis Biomerica Acurx Pharmaceuticals Creative Medical Technology Phio Pharmaceuticals Sensei Biotherapeutics Neuphoria Therapeutics Inc. - Common Stock Brainstorm Cell Therapeutics Addex Therapeutics Palatin Technologies (NYSE:PTN) and Cyclerion Therapeutics (NASDAQ:CYCN) are both small-cap manufacturing companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership, risk and community ranking. Which has higher valuation & earnings, PTN or CYCN? Cyclerion Therapeutics has higher revenue and earnings than Palatin Technologies. Cyclerion Therapeutics is trading at a lower price-to-earnings ratio than Palatin Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPalatin Technologies$350K6.99-$40.31M-$1.55-0.06Cyclerion Therapeutics$2.08M4.87-$5.26M-$1.16-2.72 Does the media prefer PTN or CYCN? In the previous week, Palatin Technologies had 1 more articles in the media than Cyclerion Therapeutics. MarketBeat recorded 1 mentions for Palatin Technologies and 0 mentions for Cyclerion Therapeutics. Palatin Technologies' average media sentiment score of 0.00 equaled Cyclerion Therapeutics'average media sentiment score. Company Overall Sentiment Palatin Technologies Neutral Cyclerion Therapeutics Neutral Which has more risk & volatility, PTN or CYCN? Palatin Technologies has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500. Comparatively, Cyclerion Therapeutics has a beta of 1.67, meaning that its share price is 67% more volatile than the S&P 500. Do insiders & institutionals hold more shares of PTN or CYCN? 11.5% of Palatin Technologies shares are owned by institutional investors. Comparatively, 75.6% of Cyclerion Therapeutics shares are owned by institutional investors. 7.1% of Palatin Technologies shares are owned by insiders. Comparatively, 34.3% of Cyclerion Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the MarketBeat Community believe in PTN or CYCN? Cyclerion Therapeutics received 34 more outperform votes than Palatin Technologies when rated by MarketBeat users. Likewise, 58.62% of users gave Cyclerion Therapeutics an outperform vote while only 0.00% of users gave Palatin Technologies an outperform vote. CompanyUnderperformOutperformPalatin TechnologiesOutperform VotesNo VotesUnderperform Votes5100.00% Cyclerion TherapeuticsOutperform Votes3458.62% Underperform Votes2441.38% Is PTN or CYCN more profitable? Palatin Technologies' return on equity of 0.00% beat Cyclerion Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Palatin TechnologiesN/A N/A N/A Cyclerion Therapeutics N/A -55.32%-48.35% SummaryCyclerion Therapeutics beats Palatin Technologies on 8 of the 13 factors compared between the two stocks. Get Palatin Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for PTN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PTN vs. The Competition Export to ExcelMetricPalatin TechnologiesPharmaceutical Preparations IndustryManufacturing SectorNYSE ExchangeMarket Cap$2.45M$6.45B$2.02B$19.27BDividend YieldN/A2.63%2.65%3.84%P/E Ratio-0.068.3722.7634.41Price / Sales6.99258.3662.1534.86Price / CashN/A65.8551.7217.51Price / BookN/A6.412.074.69Net Income-$40.31M$143.73M-$330.96M$1.02B7 Day PerformanceN/A0.29%-0.46%-2.38%1 Month PerformanceN/A0.13%6.87%4.34%1 Year PerformanceN/A0.23%14.71%4.86% Palatin Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PTNPalatin TechnologiesN/A$0.09-44.6%N/AN/A$2.45M$350,000.00-0.0630Analyst ForecastGap DownHigh Trading VolumeCYCNCyclerion Therapeutics0.8032 of 5 stars$3.04+4.1%N/A+10.3%$9.76M$2.08M-2.4930ORGSOrgenesisN/A$2.01-6.5%N/AN/A$9.65M$662,000.000.00150News CoverageGap DownBMRABiomerica0.1446 of 5 stars$3.64-0.8%N/A-39.5%$9.27M$5.68M-10.7160News CoverageACXPAcurx Pharmaceuticals2.7635 of 5 stars$0.39+3.7%$8.00+1,967.2%-84.7%$9.09MN/A-0.363CELZCreative Medical TechnologyN/A$2.02flatN/A-54.1%$8.86M$11,000.00-0.535PHIOPhio Pharmaceuticals3.1791 of 5 stars$1.84+3.4%$4.00+117.4%-74.7%$8.79MN/A-0.1710Positive NewsSNSESensei Biotherapeutics3.9079 of 5 stars$0.34-1.1%$4.25+1,135.5%-79.6%$8.67MN/A-0.2940Positive NewsGap DownNEUPNeuphoria Therapeutics Inc. - Common Stock1.7131 of 5 stars$4.92+3.8%$21.00+326.8%N/A$8.64M$662,715.000.00N/APositive NewsEarnings ReportBCLIBrainstorm Cell Therapeutics3.9737 of 5 stars$1.32+13.8%$30.00+2,172.7%-87.5%$8.61MN/A-0.2840Analyst ForecastHigh Trading VolumeADXNAddex Therapeutics1.647 of 5 stars$8.04-1.0%$30.00+273.4%-6.9%$8.52M$556,045.00-23.6330Gap Up Related Companies and Tools Related Companies Cyclerion Therapeutics Alternatives Orgenesis Alternatives Biomerica Alternatives Acurx Pharmaceuticals Alternatives Creative Medical Technology Alternatives Phio Pharmaceuticals Alternatives Sensei Biotherapeutics Alternatives Neuphoria Therapeutics Inc. - Common Stock Alternatives Brainstorm Cell Therapeutics Alternatives Addex Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:PTN) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMemorial Day Sale! Save 85% on Weiss Crypto Investor!President Trump just made his first big crypto move … Announcing the creation of a national strategic reser...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palatin Technologies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Palatin Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PTN Stock Free PTN Stock Alerts